A total of 23 military hospitals have been approved as stem cell clinical research filing institutions!

2024 China Stem Cell Industry Market Research Report

Among the encouraged categories, cell culture, cell therapy drugs, and high-end intelligent pharmaceutical equipment are included in the list of encouraged industries.

iPSC-MSC is the product with the most potential to replace adult MSC.

iPSC-MSC is the product with the most potential to replace adult MSC.

iPSC-MSC is the product with the most potential to replace adult MSC.

The Xuhui District Market Supervision Bureau and 10 medical institutions jointly issued Shanghai City's first "Guidelines for the Quality Management of Cell Therapy Drugs Used in Medical Institutions"

Human induced pluripotent stem cells (hiPSC) are derived from reprogrammed adult cells and have great prospects in disease modeling, personalized medicine, drug development and regenerative therapies.